eli lilly pill glp 1 Ground News | Federal regulators approved Lilly's new weight-loss pill, orforglipron, giving patients a second daily oral GLP-1 treatment for obesity FDA approves Eli Lilly's GLP-1

The results of the ATTAIN-MAINTAIN trial, published May 12 in Nature Medicine, showed that switching to the once-daily orforglipron pill may address this need and help maintain the cardiometabolic benefits

Maintenance dosing is a big part of the plan that needs to be put in place. The right maintenance dosing can look different for everyone, according to Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California

They're taken to support the body's master antioxidant system, support skin radiance and an even tone, support immunity, and aid the liver's natural detoxification pathways

GLP-1 Complete

Not preventing need for surgery or dramatically changing outcomes

doi: 10.1016/S1071-9164(96)80080-7